How do I find clinical trials in the UK?

Use TrialConnect to search by condition, location, or eligibility. We index over 29,000 UK clinical trials from ClinicalTrials.gov, updated daily. Enter your condition and we show matching trials near you.

Are there paid clinical trials in the UK?

Yes. Healthy volunteers can earn £500–£3,000 for Phase 1 and bioequivalence studies. TrialConnect lists paid research studies at UK research units in London, Leeds, Nottingham, and more.

What conditions have clinical trials available?

TrialConnect covers 41 conditions including breast cancer, lung cancer, diabetes, heart failure, COPD, multiple sclerosis, Parkinson's disease, Crohn's disease, and many more.

Is TrialConnect free?

Yes. TrialConnect is completely free for patients. We are not affiliated with the NHS or NIHR. Data is sourced from ClinicalTrials.gov.

Am I eligible for a clinical trial?

Each trial has specific eligibility criteria including age, condition, medical history, and current treatments. TrialConnect shows you trials that may match your situation, but only the trial team can confirm eligibility.

E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe

View on ClinicalTrials.gov ↗

At a glance

What the study gets you: Health checks and monitoring — no treatment given
Type of study: Observational (no treatment given)
Time in hospital: In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention: Not specified by the sponsor
How long the study runs: Study runs about 82 months (dates as stated)
About the drug or intervention: Not specified by the sponsor
Patient visit burden: Not specified by the sponsor

In plain English

E²-RADIatE is a Europe-wide study about radiotherapy (cancer treatment that uses radiation), run by the European Organisation for Research and Treatment of Cancer (EORTC). It is for people aged 12 and over whose cancer has been confirmed by laboratory tests and who are already due to have radiotherapy. Everyone who joins must be matched to at least one group within the study, called a cohort.

Who can take part

You are aged 12 or older.
Your cancer has been confirmed by tests on tissue or cells in a laboratory.
You are already due to have radiotherapy as part of your cancer care.
You give written informed consent (permission) to take part, following the legal and ethical rules that apply.
The study team has confirmed that you fit into at least one of the study's groups (cohorts).

Who may not be able to

Not stated — ask the trial team

What taking part involves

• Radiotherapy that is already planned as part of your cancer treatment.
• Any other tests, scans or procedures involved in the study: Not stated — ask the trial team

Time commitment: Number of visits, how long it lasts and what taking part involves: Not stated — ask the trial team.

Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.

Type of study: Observing health over time
Ages: 12 Years and over
Who: All
Number of participants: 2,000
Started: 2019-06-24
Last checked: 2025-03

Plain English Summary

What is this study?

• Testing a new treatment for cancer
• Clinical study - 2,000 participants
• The primary objective is the collection of real-world data of cancer patients treated with radiotherapy, to support radiotherapy research and to provide evidence of the role of radiation oncology in a multidisciplinary approach

Who can take part?

• Ages 12 Years and over
• Diagnosed with cancer

Where?

• Aberdeen - NHS Grampian - Aberdeen Royal Infirmary
• Cardiff - Velindre NHS Trust - Velindre Cancer Centre
• Glasgow - NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital
• Manchester - The Christie NHS Foundation trust - The Christie NHS Foundation Trust
• +3 more UK sites

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

The primary objective is the collection of real-world data of cancer patients treated with radiotherapy, to support radiotherapy research and to provide evidence of the role of radiation oncology in a multidisciplinary approach. This is an open ended prospective non-interventional non-therapeutic multi-cohort study.

Cancer

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search

Age· Tell us your age for better matching

Gender· Tell us your sex for better matching

Still need:

• Tell us your age for better matching
• Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

Age: 12 Years and over
Who can join: All genders

What the study is looking for

✓Pathologically confirmed cancer.
✓Written agreement to take part for E²-RADIatE according to applicable legal and ethical requirements
✓Planned use of radiotherapy
✓Eligibility of the patient confirmed for at least one cohort confirmed
✓Patients of 12 years and older

See the full criteria

Inclusion Criteria: * Pathologically confirmed cancer. * Written informed consent for E²-RADIatE according to applicable legal and ethical requirements * Planned use of radiotherapy * Eligibility of the patient confirmed for at least one cohort confirmed * Patients of 12 years and older